Asia Sentinel

Asia Sentinel

Share this post

Asia Sentinel
Asia Sentinel
Bitter Pill: Western Pharma’s Stunning Profits
Copy link
Facebook
Email
Notes
More

Bitter Pill: Western Pharma’s Stunning Profits

Asia Sentinel's avatar
Asia Sentinel
Apr 21, 2018
∙ Paid

Share this post

Asia Sentinel
Asia Sentinel
Bitter Pill: Western Pharma’s Stunning Profits
Copy link
Facebook
Email
Notes
More
Share

A drug to control Hepatitis C that the American pharmaceutical giant Gilead Sciences Ltd sells for US$1,000 a dose in the US can be had for US$14 a pill in India. And it is exactly the same drug, both manufactured by Gilead to the same specifications. Gilead made the deal to sell the pills at cheaper prices overseas while charging as much as US$80,000 f…

Keep reading with a 7-day free trial

Subscribe to Asia Sentinel to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Asia Sentinel
Publisher Privacy
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More